Last reviewed · How we verify
NCT03674762
Submerged vs. Nonsubmerged Single Laser-microgrooved Dental Implants.
NA trial testing Microgrooved dental implants in Partially Edentulous Maxilla, Mandible in 20 participants. Completed in 14 September 2018.
14 September 2018
Quick facts
| Lead sponsor | University of Roma La Sapienza |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | sequential |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 14 September 2018 |
| Primary completion | 14 September 2018 |
| Estimated completion | 14 September 2018 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Microgrooved dental implants
Conditions studied
- Partially Edentulous Maxilla, Mandible — all drugs for Partially Edentulous Maxilla, Mandible →
Sponsor
University of Roma La Sapienza
Who can join
Adults 18 to 80, any sex, with Partially Edentulous Maxilla, Mandible. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Aim: to evaluate and compare radiographic marginal bone loss (MBL) and soft tissue parameters around submerged/two-stage and nonsubmerged/one-stage single implants with same tapered body design and surface, same thread design and distance, and same collar surface (laser-microgrooved), after 3 years of loading.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Clinical and radiographics results at 3 years of RCT with split-mouth design of submerged vs. nonsubmerged single laser-microgrooved implants in posterior areas.
Guarnieri R, Di Nardo D, Di Giorgio G, Miccoli G, et al · · 2019 · cited 4× · PMID 31848762 · DOI 10.1186/s40729-019-0196-0
Verify or expand the search:
- PubMed search for NCT03674762
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Roma La Sapienza trials
Trials by the same sponsor.
- NCT07485023 — Oral Versus Intravenous Iron for Anemia Diagnosed After 34 Weeks of Gestation · NA · not yet recruiting
- NCT07305519 — The Combined Effect of Magnesium, Palmitoylethanolamide, High-Molecular-weight Hyaluronic Acid, Vitamin B6, and Vitamin · NA · not yet recruiting
- NCT07520968 — ABX Versus CHX in NSPT: a RCT · NA · active not recruiting
- NCT07109596 — Integration of Clinical, Biological and Psycho-social Variables for a Gender-sensitive Frailty Prediction · recruiting
- NCT07490574 — Trial of Underwater Versus Gas-Insufflation Colorectal Endoscopic Submucosal DisseEtion · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03674762 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Roma La Sapienza
- Last refreshed: 18 September 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03674762.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing